• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Mylan

Mylan

Lord Abbett Small Cap Value R3 LRSRX 3 Star

Last Price$20.77Day Change (%)0.10%
Open Price$20.77Day Change ($)0.02
Day Range20.77–20.7752-Week Range19.83–24.75

As of Fri 03/24/2017 | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  5. Research
  1. Global Epinephrine Autoinjector Market to Grow at a CAGR of 14.58%, 2017-2021 with ALK-Abell, Impax Laboratories, Lincoln Medical & Mylan Dominating - Research and Markets

    Global Epinephrine Autoinjector Market to Grow at a CAGR of 14.58%, 2017-2021 with ALK-Abell, Impax Laboratories, Lincoln Medical & Mylan Dominating - Research and Markets

  2. Rate Hikes? Not in 2015

    Watson Pharmaceuticals WPI scored big Tuesday when the Food and Drug Administration approved the firm's generic fentanyl patch. We may modestly increase our fair value estimate for Watson and will maintain our fair value estimate for competitor Mylan Laboratories MYL . The pain patch is one of the ...

  3. What Migration Can (and Can’t) Do for a Country’s GDP

    Mylan Laboratories MYL reported impressive second-quarter results Wednesday. However, most of the improvement was temporary and will not affect our fair value estimate. The quarter was only slightly better than we expected after excluding a one-time litigation payment and proceeds from a product ...

  4. UPDATE: Why PTC Therapeutics may have to lower the price on a $89,000-a-year drug it just bought

    UPDATE: Why PTC Therapeutics may have to lower the price on a $89,000-a-year drug it just bought

  5. Why PTC Therapeutics may have to lower the price on a $89,000-a-year drug it just bought

    Why PTC Therapeutics may have to lower the price on a $89,000-a-year drug it just bought

  6. UPDATE: Trump's 'Obamacare Lite' presents opportunities and perils for investors

    UPDATE: Trump's 'Obamacare Lite' presents opportunities and perils for investors

  7. Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry 2017 - Research and Markets

    Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry 2017 - Research and Markets

  8. Increasing Prevalence of Allergies to Boost the Global Epinephrine Autoinjector Market Through 2021, Reports Technavio

    Increasing Prevalence of Allergies to Boost the Global Epinephrine Autoinjector Market Through 2021, Reports Technavio

  9. MARKET SNAPSHOT: Stock Markets Roar To Records After Trump Speech

    MARKET SNAPSHOT: Stock Markets Roar To Records After Trump Speech

  10. UPDATE: Stock markets roar to records after Trump speech

    UPDATE: Stock markets roar to records after Trump speech

1234

©2017 Morningstar Advisor. All right reserved.